DSGN
Design TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
DSGN vs peer average
25/100
DSGN vs. peer average (D vs. B)
Grade spread
A 3 · B 1 · C 3 · D 2
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
ABUS is the first available peer comparator.
Loose same-sector small-cap biopharma comparator; useful mainly for development-stage and financing-risk context, not a direct indication peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
DSGN
Design Therapeutics
ABUS
Arbutus Biopharma
Grade
D
B
Momentum
76
66
Value
41
56
Sentiment
54
69
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs ABUS
DSGN / ABUS
Grade Position
Below peers
DSGN vs. peer average (D vs. B)
25/100
Momentum
76
DSGNValue
41
ABUSSentiment
54
ABUSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs DSGN
ABUS is the first peer returned for this comparison set.